Key Summary: CMR substances are chemicals classified as Carcinogenic (C), Mutagenic (M), or Reprotoxic (R) – the most serious health hazard category in EU workplace regulation. Under the CLP Regulation (EC 1272/2008), CMR substances are classified into Category 1A (known, based on human evidence), Category 1B (presumed, based on animal evidence), or Category 2 (suspected). Categories 1A and 1B carry the same regulatory weight and trigger the strictest workplace obligations, including substitution requirements. In the Netherlands, the SZW list is the official register of CMR substances. Key H-statements include H350 (cancer), H340 (genetic defects), and H360 (reproductive harm).
CMR substances — Carcinogenic, Mutagenic, and Reprotoxic — represent the most serious category of health hazards in the workplace. Exposure to these substances can cause cancer, heritable genetic damage, or adverse effects on reproductive function and the development of offspring. Because of their severity, CMR substances are subject to the strictest regulatory requirements in the European Union and carry specific obligations for employers.
What Are CMR Substances?
CMR is an abbreviation that groups three types of chronic health effects:
Carcinogenic (C): Substances that cause cancer or increase its incidence. Carcinogens may act through genotoxic mechanisms (directly damaging DNA) or non-genotoxic mechanisms (promoting tumor growth through other pathways). Examples include benzene, formaldehyde, hexavalent chromium compounds, and crystalline silica dust.
Mutagenic (M): Substances that cause heritable mutations in the genetic material of germ cells. This means the genetic damage can be passed to future generations. Mutations may involve changes to individual genes, chromosome structure, or chromosome number. Examples include ethylene oxide and certain aromatic amines.
Reprotoxic (R): Substances that adversely affect sexual function, fertility, or the development of offspring. This includes effects on male and female fertility, developmental toxicity to the embryo or fetus, and effects on lactation. Examples include lead compounds, certain glycol ethers (such as 2-methoxyethanol), and some phthalates.
Classification Categories Under CLP
The CLP Regulation (EC 1272/2008) classifies CMR substances into categories that reflect the strength of evidence:
Category 1A — Known CMR
Classification based on human evidence. Sufficient data from human epidemiological studies demonstrate that the substance causes cancer, heritable genetic defects, or reproductive harm in humans. This is the highest level of evidence.
Category 1B — Presumed CMR
Classification based on animal evidence. Sufficient data from animal studies, supplemented by other information, provide a strong presumption that exposure to the substance will cause CMR effects in humans. The distinction between 1A and 1B reflects the source of evidence (human vs. animal), not the severity of concern — both categories carry the same regulatory weight.
Category 2 — Suspected CMR
Classification based on limited evidence. The available data from human or animal studies are suggestive but not sufficiently convincing to place the substance in Category 1. These substances are labeled as “suspected” carcinogens, mutagens, or reprotoxicants.
The corresponding H-statements are:
| Effect | Category 1A/1B | Category 2 |
|---|---|---|
| Carcinogenic | H350 — May cause cancer | H351 — Suspected of causing cancer |
| Mutagenic | H340 — May cause genetic defects | H341 — Suspected of causing genetic defects |
| Reprotoxic | H360 — May damage fertility or the unborn child | H361 — Suspected of damaging fertility or the unborn child |
The SZW List: Dutch CMR Substances Register
In the Netherlands, the Ministry of Social Affairs and Employment (SZW) maintains an official list of CMR substances, commonly known as the SZW-lijst. This list is published annually in the Staatscourant (Government Gazette) and includes all substances classified as carcinogenic (Category 1A or 1B), mutagenic (Category 1A or 1B), or reprotoxic (Category 1A or 1B) under the CLP Regulation.
The SZW list is based on Annex VI to the CLP Regulation (harmonized classifications) and is updated each year to reflect new classifications and reclassifications. It serves as the definitive reference for Dutch employers to determine which substances in their workplace are subject to the enhanced CMR regulations.
DOHSBase integrates the SZW list and flags substances accordingly, allowing users to immediately identify whether a substance carries CMR obligations under Dutch law.
Employer Obligations for CMR Substances
The presence of CMR substances in the workplace triggers specific legal obligations that go beyond standard chemical risk management:
Registration and Inventory
Employers must maintain a register of all CMR Category 1A and 1B substances present in the workplace, including where they are used, which workers may be exposed, and the nature and degree of exposure. In the Netherlands, this obligation is codified in the Arbeidsomstandighedenbesluit (Working Conditions Decree).
Substitution Principle
The substitution principle requires employers to replace CMR substances with less hazardous alternatives wherever technically feasible. This is not merely a recommendation — it is a legal obligation. If substitution is not feasible, the employer must document why and demonstrate that all reasonable efforts have been made to find alternatives.
Minimization
When substitution is not possible, employers must minimize exposure to the lowest technically achievable level. This goes beyond simply staying below a limit value — the obligation is to reduce exposure as far as reasonably practicable, using a hierarchy of controls (elimination, engineering controls, organizational measures, personal protective equipment).
Health Surveillance
Workers exposed to CMR substances are entitled to periodic health surveillance (Periodiek Arbeidsgezondheidskundig Onderzoek — PAGO). The purpose is to detect early signs of adverse health effects and to verify the effectiveness of workplace controls.
Exposure Records
Employers must maintain records of worker exposure to CMR substances. In the Netherlands, these records must be kept for at least 40 years after the last exposure, reflecting the long latency period of many CMR effects (particularly cancer).
How to Identify CMR Substances
Multiple authoritative sources provide CMR classification data:
ECHA Harmonized Classifications (Annex VI to CLP)
The most authoritative EU-level source. Harmonized classifications are established through a formal evaluation process involving RAC (Committee for Risk Assessment) and are legally binding across all EU member states. When a substance has a harmonized CMR classification, all manufacturers and importers must apply it.
IARC Monographs
The International Agency for Research on Cancer (IARC), part of the WHO, evaluates the carcinogenic potential of substances and publishes its findings in monographs. IARC classifications (Group 1: carcinogenic, Group 2A: probably carcinogenic, Group 2B: possibly carcinogenic) are widely used as a reference by regulatory agencies worldwide, though they are not directly legally binding in the EU.
Health Council of the Netherlands (Gezondheidsraad)
The Dutch Health Council independently evaluates the carcinogenicity and genotoxicity of substances and advises on health-based limit values. Their evaluations are particularly relevant for substances that may not yet have a harmonized EU classification.
ACGIH Carcinogenicity Assessments
The American Conference of Governmental Industrial Hygienists classifies substances as A1 (confirmed human carcinogen), A2 (suspected human carcinogen), A3 (confirmed animal carcinogen), A4 (not classifiable), or A5 (not suspected as human carcinogen). These designations are included in DOHSBase alongside TLV values.
National Lists
Besides the Dutch SZW list, several other countries maintain CMR substance registers. Germany’s MAK Commission publishes carcinogenicity categories, and France maintains its own CMR classification list.
CMR Data in DOHSBase
DOHSBase provides comprehensive CMR identification by integrating data from multiple sources in a single substance profile:
- ECHA harmonized classifications — the legally binding EU classifications with H340, H350, H360 indicators
- IARC evaluations — carcinogenicity group classifications for substances evaluated by IARC
- SZW-lijst status — flagging whether a substance appears on the Dutch CMR list
- ACGIH carcinogenicity designations — A1 through A5 classifications
- Health Council evaluations — Dutch health-based assessments and recommendations
- REACH DNELs — where available, DNEL values that may incorporate CMR-related assessment factors
This multi-source approach means that DOHSBase can identify CMR substances that might be missed when consulting only a single source. A substance might not yet have a harmonized EU classification but could be classified by IARC or the Health Council — DOHSBase shows all available assessments.
Combined with the limit value hierarchy and GHS classification data, this gives occupational hygienists a complete picture of both the qualitative hazard profile and the quantitative exposure benchmarks available for CMR substances.
The Role of DOHSBase in CMR Compliance
For organizations managing CMR substances, DOHSBase serves as a central reference that answers key compliance questions:
- Is this substance a CMR? — Check harmonized classification, IARC evaluation, SZW list status
- What is the applicable limit value? — See the limit value hierarchy from legal OELs through DNELs to kick-off values
- What are the hazard details? — View H-statements, pictograms, and source evaluations
- Are there substitution candidates? — Compare substances within the same functional group
With over 200,000 substances in the database, DOHSBase provides the data foundation that employers and occupational hygienists need to fulfill their CMR obligations systematically and defensibly.